![Doug Gentilcore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Doug Gentilcore formerly worked at Jubilant DraxImage, Inc., as Vice President-Global Sales & Business Operations, Y-mAbs Therapeutics, Inc., as Senior VP & Head-Danyelza Business Unit in 2025, and ARTMS, Inc., as Chief Commercial Officer.
Mr. Gentilcore received his undergraduate degree from Randolph-Macon College.
Eerdere bekende functies van Doug Gentilcore
| Bedrijven | Functie | Einde |
|---|---|---|
| YMAS THER | Corporate Officer/Principal | 16-09-2025 |
Jubilant Draximage, Inc.
 Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes radiopharmaceuticals products for heart, thyroid, lung & bone disease | Verkoop & Marketing | - |
ARTMS, Inc.
 ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Algemeen Directeur | - |
Opleiding van Doug Gentilcore
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
5
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Randolph-Macon College
 Randolph-Macon College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jubilant Draximage, Inc.
Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes radiopharmaceuticals products for heart, thyroid, lung & bone disease | Health Technology |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
